- Home
- CMBT vs CNTA Comparison
CMBT vs CNTA Comparison
Compare CMBT & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBT
- CNTA
- Stock Information
- Founded
- CMBT 1989
- CNTA 2020
- Country
- CMBT Belgium
- CNTA United Kingdom
- Employees
- CMBT N/A
- CNTA N/A
- Industry
- CMBT
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- CMBT
- CNTA Health Care
- Exchange
- CMBT NYSE
- CNTA Nasdaq
- Market Cap
- CMBT 2.0B
- CNTA 2.3B
- IPO Year
- CMBT N/A
- CNTA 2021
- Fundamental
- Price
- CMBT $11.09
- CNTA $15.16
- Analyst Decision
- CMBT
- CNTA Strong Buy
- Analyst Count
- CMBT 0
- CNTA 8
- Target Price
- CMBT N/A
- CNTA $23.71
- AVG Volume (30 Days)
- CMBT 100.2K
- CNTA 489.7K
- Earning Date
- CMBT 01-30-2025
- CNTA 11-12-2024
- Dividend Yield
- CMBT 47.65%
- CNTA N/A
- EPS Growth
- CMBT 75.60
- CNTA N/A
- EPS
- CMBT 5.97
- CNTA N/A
- Revenue
- CMBT $982,850,000.00
- CNTA $6,853,000.00
- Revenue This Year
- CMBT N/A
- CNTA N/A
- Revenue Next Year
- CMBT $20.93
- CNTA N/A
- P/E Ratio
- CMBT $1.86
- CNTA N/A
- Revenue Growth
- CMBT N/A
- CNTA N/A
- 52 Week Low
- CMBT $8.59
- CNTA $7.38
- 52 Week High
- CMBT $21.26
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- CMBT 54.02
- CNTA 41.38
- Support Level
- CMBT $10.40
- CNTA $14.44
- Resistance Level
- CMBT $12.00
- CNTA $17.65
- Average True Range (ATR)
- CMBT 0.39
- CNTA 1.01
- MACD
- CMBT 0.21
- CNTA -0.21
- Stochastic Oscillator
- CMBT 58.82
- CNTA 20.22
About CMBT EURONAV
CMB.Tech NV owns and operates a fleet of vessels for international maritime shipping and storage of crude oil and petroleum products. It generate a large parts of their revenue from voyage charters, including vessels in pools that predominantly perform voyage charters. The company organises itself into two segments: tankers and floating storage and offloading activities, or FSO. The tankers segment, which generates the majority of revenue, operates crude oil tankers on international markets. The FSO segment conducts floating production, floating storage, and offloading operations for crude oil and petroleum products.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.